Socioeconomic position and region differences did not explain most of the differences in post-lung transplant survival by race and ethnicity, highlighting the complex social reality in racial disparities in post-transplant outcomes. ja.ma/3MXxGgS

Great talk from Kamal Ayyat on the screening for donor PE during EVLP from #clevelandclinic #lungtransplant Marie Budev James Yun Haytham Elgharably

Great Invited Expert Opinion in #JTCVS comparing longevity of patients with cystic fibrosis in the US vs Canada. By Dr Joel Cooper et al: doi.org/10.1016/j.jtcv… AATS CTSurgSocMedNetwork Maryam Valapour Marcelo Cypel Plus a Commentary by Harris, Matthew Hartwig et al: doi.org/10.1016/j.jtcv…

To keep up to date with all the happenings at NIH NHLBI Follow us there for the latest heart, lung, blood and sleep news, research results, funding opportunities, and more. Learn more: bit.ly/3iiB0Gk.

2021 ADR | The full report can be downloaded from our website: ow.ly/Igb150NJniH #transplantation #transplant

Caroline Patterson Thank you for your kind words Caroline Patterson. We hope this informs clinical practice and impacts urgency-based allocation both in the US and internationally. Maryam Valapour JHLT EuroELSO ELSO

New 🇺🇸 data demonstrates higher than previously reported waitlist mortality for 🫁#transplant candidates supported with ECMO. Important work by Carli Lehr & Maryam Valapour ⬇️⬇️⬇️⬇️ sciencedirect.com/science/articl…

NIH NHLBI Thank you NIH NHLBI for supporting and highlighting our work! Maryam Valapour

Association of Socioeconomic Position With Racial and Ethnic Disparities in Survival After #Lung #Transplant | ow.ly/yN9v50O0hhv #lungtransplant #transplantation #transplant #fridayreads #weekendreads

Racial Disparities Among #Lung #Transplant Survivors—Shadows and Substance | ow.ly/2Jn950OmxlT #lungtransplant #transplantation

Congrats Sumita Khatri !! ❤️❤️❤️

Great session on complications in lung transplant ⁦Carli Lehr⁩ ⁦Lorenzo Zaffiri⁩ ⁦AmericanTransplantCongress⁩ #ATC2023SanDiego

Thank you Max Miller for supporting and highlighting our Quantum program Cleveland Clinic. We are committed to #research in #healthcare and life sciences. The #ClevelandInnovationDistrict is busy at work and open for innovators to partner! U.S. National Science Foundation NIH Connected DMV #QuantumWorldCongress IBM Research

" ... racial differences in post-transplant outcomes still exist and must be studied further to achieve improved #equity in the U.S. #transplant system," Carli Lehr, at Cleveland Clinic, told Healio. bit.ly/46VrEor

If you haven't already transported yourself away from X, here's my latest paper on transportability: onlinelibrary.wiley.com/doi/10.1111/bi… Featuring: adaptive treatment strategies, kidney-pancreas transplant, David Vock, SRTR, and more!

Cleveland Clinic researchers develop a new model for prioritizing patients waiting for a lung transplant. The goal is to improve outcomes and reduce deaths among those in need of donor lungs. cle.clinic/3PSVEuC

Tune in now to ideastream.org// to hear Maryam Valapour and Jarrod Dalton discuss our recent work optimizing lung allocation models pubmed.ncbi.nlm.nih.gov/37771035/ Cleveland Clinic CCF Pulmonary and Critical Care Fellows

Higher utilization of ECMO bridge to transplant and increased waitlist mortality found using newly collected OPTN/UNOS data. Continued efforts are needed to ensure timely access to transplant for this population. @CarliLehrMD Maryam Valapour 🔗: jhltonline.org/article/S1053-…

Is there a better way to capture waitlist mortality risk for #LungTx patients? Using clinically-interpretable dimensions leads to improved phenotyping and better understanding of mortality risk. Carli Lehr Maryam Valapour Jarrod Dalton 🔗jhltonline.org/article/S1053-…

The cost of end-of-life hospitalizations for lung disease varies widely, averaging $29,981 per patient; this raises the question of whether lung transplantation could avert acute care costs for some patients. Carli Lehr Jarrod Dalton Maryam Valapour brnw.ch/21wH5mS